FDAClass IIMay 8, 2024

Prednisolone Sodium Phosphate-Moxifloxacin-Bromfenac recall: Subpotent

Prednisolone Sodium Phosphate-Moxifloxacin-Bromfenac Sterile Ophthalmic Solution 1%, 0.5%, 0.075%, 8mL, Compounded By: Imprimis NJOF, LLC. 1705 Route…

Why was Prednisolone Sodium Phosphate-Moxifloxacin-Bromfenac recalled?

Subpotent Drug

What should I do if I have this product?

The recall is ongoing. Follow the firm and FDA instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

Lot #: 23JUN031; Exp. 07/03/2024

Product
Prednisolone Sodium Phosphate-Moxifloxacin-Bromfenac Sterile Ophthalmic Solution 1%, 0.5%, 0.075%, 8mL, Compounded By: Imprimis NJOF, LLC. 1705 Route…
Recalling firm
Imprimis NJOF, LLC
Quantity
3320 bottles
Distribution
U.S. Nationwide
Recall date
May 8, 2024
Classification
Class II
Status
Ongoing
Agency
FDA (drug)
Open FDA enforcement record Latest recalls